Education
About Us
Working with TipRanks
Follow Us
Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
FTRE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.77 - $38.04
Previous CloseN/A
Volume188.47K
Average Volume (3M)2.77M
Market Cap
$533.98M
Enterprise Value$2.75B
Total Cash (Recent Filing)$118.50M
Total Debt (Recent Filing)$148.80M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
May 12, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.45
Shares Outstanding90,200,000
10 Day Avg. Volume2,430,739
30 Day Avg. Volume2,770,802
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.29
Price to Cash Flow (P/CF)11.60
P/FCF Ratio14.20
Enterprise Value/Market Cap5.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.15
Enterprise Value/Ebitda-41.77
Forecast
1Y Price Target
$9.00Price Target Upside52.03% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Fortrea Holdings Inc. News
See All FTRE News
---
Bulls Say, Bears Say
Bulls Say
Bookings PerformanceThe company continues to see growth in its bookings, with a stronger than expected book-to-bill ratio of 1.35x for the quarter.
Restructuring BenefitsFTRE has initiated restructuring programs leading to significant savings in net SG&A expenses, with further improvements expected in the following years.
Venture Capital FundingBiopharma funding from venture capital increased by 22% year-over-year, which is viewed as positive given biotech makes up a significant portion of FTRE's portfolio.
Bears Say
Communication StrategyFTRE abruptly cancelled two conferences and our planned vNDR, raising concerns about the company's communication strategy.
Earnings PerformanceFTRE's Q4:24 results missed expectations, with adjusted EPS and EBITDA significantly below consensus estimates.
Revenue OutlookManagement introduced 2025 guidance that was below street expectations.
---
Ownership Overview
0.35% Insiders
22.76% Mutual Funds
1.62% Other Institutional Investors
46.42% Public Companies and
Individual Investors
FTRE FAQ
What was Fortrea Holdings Inc.’s price range in the past 12 months?
Fortrea Holdings Inc. lowest stock price was $4.77 and its highest was $38.03 in the past 12 months.
What is Fortrea Holdings Inc.’s market cap?
Fortrea Holdings Inc.’s market cap is $533.98M.
When is Fortrea Holdings Inc.’s upcoming earnings report date?
Fortrea Holdings Inc.’s upcoming earnings report date is May 12, 2025 which is in 13 days.
How were Fortrea Holdings Inc.’s earnings last quarter?
Fortrea Holdings Inc. released its earnings results on Mar 03, 2025. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.365 by -$0.185.
Is Fortrea Holdings Inc. overvalued?
According to Wall Street analysts Fortrea Holdings Inc.’s price is currently Undervalued.
Does Fortrea Holdings Inc. pay dividends?
Fortrea Holdings Inc. does not currently pay dividends.
What is Fortrea Holdings Inc.’s EPS estimate?
Fortrea Holdings Inc.’s EPS estimate is -0.06.
How many shares outstanding does Fortrea Holdings Inc. have?
Fortrea Holdings Inc. has 90,200,000 shares outstanding.
What happened to Fortrea Holdings Inc.’s price movement after its last earnings report?
Fortrea Holdings Inc. reported an EPS of $0.18 in its last earnings report, missing expectations of $0.365. Following the earnings report the stock price went down -25.054%.
Which hedge fund is a major shareholder of Fortrea Holdings Inc.?
Currently, no hedge funds are holding shares in FTRE
---
Fortrea Holdings Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.00 (52.03% Upside)
$9.00 (52.03% Upside)
Blogger Sentiment
Bullish
FTRE Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.71%
12-Months-Change
Fundamentals
Return on Equity
-17.51%
Trailing 12-Months
Asset Growth
-17.86%
Trailing 12-Months
Company Description
Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
---
FTRE Company Deck
---
FTRE Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture, with strong new business wins and operational improvements offset by financial challenges from pre-spin project economics and a significant decline in profitability and revenue. The company is implementing cost-saving measures and expects long-term growth, but faces near-term financial pressures.Read More>---
FTRE Stock 12 Month Forecast
Average Price Target
$9.00
▲(52.03% Upside)
Technical Analysis
Anavex Life Sciences
―
Cogent Biosciences
―
Bioventus
―
Bicara Therapeutics Inc.
―
Ceribell, Inc.
―
---